Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017 Biogen Strikes $120 Million+ Deal For Remedy Pharma's Stroke Candidate May 14, 2017 <b>ClassPass</b> Raises $70 Million In Series C Funding Led By Temasek Life Science Ventures Pte Ltd (TLV) Following Its Strongest Quarter To Date June 18, 2017
Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017
<b>ClassPass</b> Raises $70 Million In Series C Funding Led By Temasek Life Science Ventures Pte Ltd (TLV) Following Its Strongest Quarter To Date June 18, 2017
